Modifying CAR-T cells with anti-checkpoints in cancer immunotherapy: A focus on anti PD-1/PD-L1 antibodies
Sajad Najafi, Keywan Mortezaee
Topics & Concepts
Chimeric antigen receptorImmunotherapyAntigenCancer researchTumor microenvironmentCancer immunotherapyImmune systemAntibodyCancerImmune checkpointMonoclonal antibodyImmunologyMedicineInternal medicineCAR-T cell therapy researchNanowire Synthesis and ApplicationsAdvancements in Semiconductor Devices and Circuit Design